NCT05482763View on ClinicalTrials.gov

Mycosis Culture Collection From Dermatological Isolated

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

July 20, 2025

Study Completion Date

December 25, 2025

Conditions
OnychomycosisResistant InfectionNail Diseases
Interventions
DRUG

Terbinafine Topical Gel

Topical application of terbinafine

DRUG

Itraconazole 200 mg

systemic itraconazole pulse therapy

DRUG

Terbinafine 250 mg

systemic terbinafine

DRUG

Ciclopirox Topical Gel

Topical application of ciclopirox

DRUG

Amorolfine 50 MG/ML

Topical application of amorolfine

Trial Locations (1)

00133

Tor Vergata Univerisity Hospital, Rome

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER